Tevogen (TVGN) Current Taxes (2021 - 2023)
Tevogen's (TVGN) quarterly Current Taxes came in at $182000.0 in Q1 2023, up 264.0% on a YoY basis from $50000.0 in Q1 2022, and up 30.0% quarter-over-quarter from $140000.0 in Q4 2022.
Analysis
Tevogen (TVGN) Current Taxes (2021 - 2023) Analysis & Trends
Tevogen (TVGN) has reported Current Taxes for 3 consecutive years, with $182000.0 the latest figure, recorded in Q1 2023.
- For the quarter ending Q1 2023, Current Taxes rose 264.0% year-over-year to $182000.0; the trailing twelve-month figure through Mar 2023 stood at $182000.0 (up 264.0% YoY), and the FY2022 full-year result was $140000.0, up 600.0% from the prior year.
- Current Taxes rose to $182000.0 in Q1 2023 per TVGN's latest filing, from $140000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $182000.0 in Q1 2023 and bottomed at $20000.0 in Q4 2021.
- Historically, Current Taxes has averaged $97000.0 across 3 years, with a median of $95000.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Current Taxes soared 600.0% in 2022, then jumped 264.0% in 2023.
- Over 3 years, Current Taxes stood at $20000.0 in 2021, then jumped by 600.0% to $140000.0 in 2022, then gained by 30.0% to $182000.0 in 2023.
- According to Business Quant data, Current Taxes over the past three periods registered $182000.0, $140000.0, and $110000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 494,000.00 |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 33.70 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 9.31 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | Tevogen | 27.76 Mn | 27.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 182,000.00 |
| Dec 31, 2022 | 140,000.00 |
| Sep 30, 2022 | 110,000.00 |
| Jun 30, 2022 | 80,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 20,000.00 |